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A 15-month-old boy was diagnosed with malignant hypertension caused by a catecholamine excreting
retroperitoneal paraganglioma consisting of a composite phaeochromocytoma/differentiating neuro-
blastoma. After alpha-blockade the tumor was excised. No adjuvant treatment was given, and he is doing
well eight years after the diagnosis. The patient is the ﬁrst child known to have an extra-adrenal
retroperitoneal composite tumor, and also the youngest child with a composite phaeochromocytoma/
neuroblastoma reported in the English literature.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Composite phaeochromocytoma (CP) in children is so rare that hypertension. He had heart failure with dilated left atrium, hyper-
every new case ought to be reported. In adults CP accounts for three
percent of phaeochromocytomas [1]. In children about 30% of
phaeochromocytomas are extra-adrenal (paragangliomas) [2]. CP
occurs almost exclusively in adult patients; pediatric CP is so
infrequent that meaningful estimates of incidence are precluded
[3e11]. Hereinwe report the patient history and outcome of a 15m-
old boy with malignant hypertension and a lumbar, retroperitoneal
paraganglioma consisting of a phaeochromocytoma combined with
a differentiating neuroblastoma.
1. Case presentation
At15monthsof ageaboywhohadsuffered fromprofusesweating
and increased thirst since birth was diagnosed with malignanta; HVA, homovanillic acid;
natriuretic peptide; VMA,
ce, Department of Hepatic,
Hospital, Rikshospitalet, Pb.
92.
air).
Inc. This is an open access article utrophied left ventricle and a blood pressure of 180/130. Pro Brain
Natriuretic Peptide (ProBNP)was 2420 pmol/l (reference value<35).
The ﬁrst four days in Oslo University Hospital he was sedated on
ventilator and the blood pressure was monitored invasively. He was
medicated with nitroprusside and labetalol via a central venous
line. However, troublesome, spiky hypertension and spells with
hypotension persisted, and after a week amlodipin was added and
nitroprusside tapered.
A CT study disclosed a 7  6  4 cm retroperitoneal tumor
located at the lower pole of the right kidney (Fig. 1).
Urinary catecholamine excretions were: VMA/HVA: 133/
252 mmol/mmol creatinine (reference values <10/<18), dopamine:
3489 nmol/24 h (146e2014), norepinephrine: 2726 nmol/24 h
(60e400) and epinephrine: 9 nmol/24 h (0e70).
During an MRI study in general anesthesia two days after
admission bradycardia suddenly occurred and blood pressure
became immeasurable. He was resuscitated and after about 8 min
adequate blood pressure was restored. After weaning off the
ventilator two days after the MRI-incident he was conscious but
without adequate eye contact and had rigid upper extremities. EEG
was normal but cerebral MRI revealed pronounced, diffuse cortical
hypoxic injuries.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 2. (AeE) H&E stained histological sections from different areas of the excised
tumor showing (A) a lobular growth pattern of phaeochromocytoma, while the neu-
roblastoma component (B) is characterized by diffuse distribution of differentiating
neuroblasts on a background of abundant neuropile. Cytologically the phaeochromo-
cytoma (C) is composed of more uniformly looking, tightly packed large cells with
abundant light eosinophilic cytoplasm whereas the neuroblasts (D) are generally
smaller, display a darker eosinophilic cytoplasm and comprise a spectrum of poorly
differentiated to differentiating neuroblasts. There is no sharp border between the
tumors, but a transitional zone (arrows in E) where the lobular phaeochromocytoma-
like architecture (left part of the image) is gradually broken up by an increasing
amount of neuropile surrounding small groups or single neuroblasts (right part of the
image) (A, B and E: objective 20 and identical ﬁnal magniﬁcation; C and D:
objective 40 and identical ﬁnal magniﬁcation).
Fig. 1. Axial CT taken the day after admission, showing a right-sided calciﬁed, para-
spinal tumor (white arrows) displacing the vena cava inferior (VCI) and the aorta (AO)
anteriorly (black arrows).
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taken two weeks after admission. Even normal background activity
was absent. At the time of the MIBG scan he received labetalol
15 mg/kg/day and amlodipin 0.5 mg/kg/day.
The work-up revealed no evidence of metastatic disease. A
clinical diagnosis of phaeochromocytoma was made, but Tru-Cut
biopsies taken three days after admission revealed a differentiating
neuroblastoma. The negative MIBG scan was interpreted as caused
by blocked uptake of MIBG by labetalol, an effect that has been
reported [12].
The boy received preoperative medication as if he had phae-
chromocytoma. In addition to labetalol and amlodipin he was given
terazosin 0.4 mg/kg/day to ensure effective alpha-blockade (phe-
noxybenzamine was not available).
Twenty-ﬁve days after admission and after two weeks with
normalized blood pressure he was operated with complete excision
of a 75 g ﬁrm, encapsulated retroperitoneal tumor located posterior
to the lumbar vena cava and aorta. One week after the operation
urinary excretion of VMA and HVAwere normal, respectively 7 and
12 mmol/mmol creatinine.
Histology showed a composite paraganglioma with elements of
phaeochromocytoma and differentiating neuroblastoma with low
mitosis-karyorrhexis index (Fig. 2). Details of the pathology ﬁnd-
ings are given in the ﬁgure legend.
The prognosis of the neuroblastoma component was favorable
according to the International Neuroblastoma Pathology Classiﬁ-
cation [13]. Tumor margins were free. One of six adherent lymph
nodes contained neuroblastoma tissue. There were no indicationsTable 1
Composite phaeochromocytoma/paraganglioma in children under 15 year of age.
Author Year Reference Age/Sex
Wahl et al. 1943 [3] 4 year/M
Nakagawara et al. 1985 [4] 14 year/F
Tatekawa et al. 2006 [8] 5 year/M
Ch’ng et al. 2007 [9] 9 year/F
Thiel et al. 2010 [10] 9 year/F
Kikuchi et al. 2012 [11] 12 year/F
Current case 2015 1 year/M
PH; phaeochromocytoma, NB; neuroblastoma, GNB; ganglioneuroblastoma, GN; ganglio
a With WDHA: watery diarrhea hypokalaemia achlorhydria.
b Cited from Ref. [8]: “After operation, the patient is doing well and is free from the sofMYCN ampliﬁcation, gain of 17q or loss of 1p/11q by ﬂuorescence
in situ hybridization. Array comparative genomic hybridization
(Affymetrix SNP array 6.0) did not reveal segmental, only numerical
chromosomal aberrations.Location Histology Follow-up Outcome
Mediastinum PH/NB 8 m Died
Adrenal PH/GNB 6 m Died
Adrenal PH/NB Unknownb Aliveb
Adrenal PH/MPNST 28 years Died
Adrenal PH/GNB 18 m Alive
Adrenal PH/GNa 14 years Died
Retro-peritoneum PH/NB 8 y Alive
neuroma, MPNST; malignant peripheral nerve sheath tumor.
ymptoms of hypertension.”
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after the tumor excision all neurological symptoms had subsided
and his vision was normal. The blood pressure and the function of
the heart were normalized but antihypertensive medication was
continued. One month after the operation, during which no labe-
talol was given, a repeated 123I-MIBG scan showed normal back-
ground activity but no tumor suspect areas. Also an octreotide
scintigraphy was normal. Both studies were done in order to detect
metastases. He received tapering doses of antihypertensive medi-
cation for one year. Ten months after the ischemic brain insult ce-
rebral MRI was normal.
The patient had a negative history of familial tumors and relevant
gene tests (RET, VHL, SDHB and SDHD) did not disclose mutations.
Eight years after treatment the patient is doing well without
evidence of disease. However, after starting school, he has been
diagnosed with attention deﬁcit hyperactivity disorder (ADHD),
which is successfully treated with psychostimulants.
Both parents have given informed consent to publication.
2. Discussion
Only six childrenwithCPare reported in theEnglish literature;ﬁve
tumors were adrenal and one mediastinal [3,4,8e11] (Table 1).
The youngest patient with CP was 4 years old [3]. Our patient
was diagnosed at 15 m of age, but had symptoms since birth and
had heart ﬁndings compatible with longstanding hypertension. It is
therefore likely that his catecholamine-producing tumor was pre-
sent at birth. Accordingly our patient is both the ﬁrst child reported
to have an extra-adrenal retroperitoneal CP, and also the youngest
patient with a CP.
During the ﬁrst week in hospital the patient was unstable,
posing great challenges for the treating physicians. We were
confused by the negative preoperative MIBG scan, but assume in
retrospect that it was caused by a blocking effect of the large dose of
labetalol [12]. If possible it may be wise to postpone medication
with labetalol until after diagnostic MIBG studies.
Patients with untreated phaeochromocytoma are at high risk for
circulatory collapse, and it is strongly recommended to avoid op-
erations and procedures in anesthesia until effective alpha-
blockade has been established [2,14,15]. It seems reasonable to treat
children with labile blood pressure of uncertain etiology likewise.
Accordingly, in retrospect we admit that the MRI study in our case
should not have been done. If really needed it should have been
postponed to a later time.
Many details, especially on medication, could have been elabo-
rated on, but with an eight-year retrospective viewwe have chosento focus on the aspects most relevant for the main messages of this
report: 1) Extra-adrenal CP can also occur in younger children. 2) In
hypertensive patients with suspected phaeochromocytoma opera-
tions and procedures in anesthesia should whenever possible be
postponed until effective alpha-blockade has been established. 3) In
absence of unfavorable features, patients with CP can be cured with
surgical treatment alone.
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